MedTrace Logo

Masked Faces in Parkinson Disease: Mechanism and Treatment

NCT00350402 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2012-04-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effectiveness of high intensity respiratory muscle strength training in treating blunted facial expression in people with Parkinson disease.

Conditions

Interventions

BEHAVIORAL

Respiratory muscle strength training

The Muscle Stength Training (MST)device is a mouthpiece that the participant uses to inspire against controlled resistance; Intervention involves use of this device for breathing exercises over 4 week period, 5 days a week, approximately 20 minutes/day.

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Dawn Bowers, Ph.D. · Professor and Area Head, Department of Clinical and Health Psychology, University of Florida

  • Christine Sapienza, Ph.D. · Professor and Chair, Department of Communication Sciences and Disorders, University of Florida

  • Michael S. Okun, M.D. · Assistant Professor, Co-Director Movement Disorders Program, Medical Director, National Parkinson Foundation, Department of Neurology

  • Hubert Fernandez, M.D. · Associate Professor and Director of Clinical Trials, Movement Disorder Program, Department of Neurology, University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350402 on ClinicalTrials.gov